Your browser doesn't support javascript.
loading
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Pasquier, David; Bidaut, Luc; Oprea-Lager, Daniela Elena; deSouza, Nandita M; Krug, David; Collette, Laurence; Kunz, Wolfgang; Belkacemi, Yazid; Bau, Maria Grazia; Caramella, Caroline; De Geus-Oei, Lioe-Fee; De Caluwé, Alex; Deroose, Christophe; Gheysens, Olivier; Herrmann, Ken; Kindts, Isabelle; Kontos, Michalis; Kümmel, Sherko; Linderholm, Barbro; Lopci, Egesta; Meattini, Icro; Smeets, Ann; Kaidar-Person, Orit; Poortmans, Philip; Tsoutsou, Pelagia; Hajjaji, Nawale; Russell, Nicola; Senkus, Elzbieta; Talbot, Jean-Noël; Umutlu, Lale; Vandecaveye, Vincent; Verhoeff, Joost J C; van Oordt, Willemien Menke-van der Houven; Zacho, Helle D; Cardoso, Fatima; Fournier, Laure; Van Duijnhoven, Frederieke; Lecouvet, Frédéric E.
Affiliation
  • Pasquier D; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France; University of Lille and CNRS, Centrale Lille, UMR 9189-CRIStAL, Lille, France. Electronic address: d-pasquier@o-lambret.fr.
  • Bidaut L; College of Science, University of Lincoln, Lincoln, UK.
  • Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • deSouza NM; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Krug D; Department of Radiation Oncology, Universitaetsklinikum Schleswig-Holstein-Campus Kiel, Kiel, Germany.
  • Collette L; Former European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Kunz W; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Belkacemi Y; AP-HP, Radiation Oncology Department, Henri Mondor University Hospital, Créteil, France; INSERM Unit 955 (-Bio), IMRB, University of Paris-Est (UPEC), Créteil, France.
  • Bau MG; Azienda Ospedaliera Città della Salute e della Scienza di Torino, Ospedale Sant'Anna, Turin, Italy.
  • Caramella C; Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
  • De Geus-Oei LF; Department of Radiology, Leiden University Medical Center, Leiden, Netherlands; Biomedical Photonic Imaging Group, University of Twente, Enschede, Netherlands; Department of Radiation Science and Technology, Delft University of Technology, Delft, Netherlands.
  • De Caluwé A; Radiotherapy Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Deroose C; Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Gheysens O; Department of Nuclear Medicine, Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint-Luc, Institut du Cancer Roi Albert II, UCLouvain, Brussels, Belgium.
  • Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany.
  • Kindts I; Department of Radiation Oncology, Cancer Centre, General Hospital Groeninge, Kortrijk, Belgium.
  • Kontos M; National and Kapodistrian University of Athens, Athens, Greece.
  • Kümmel S; Breast Unit, Kliniken Essen-Mitte, Essen, Germany; Charité - Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Berlin, Germany.
  • Linderholm B; Department of Oncolgy, Sahlgrenska University Hospital, Gothenburg, Sweden; Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg , Sweden.
  • Lopci E; IRCCS Humanitas Research Hospital, Milan, Italy.
  • Meattini I; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Smeets A; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Kaidar-Person O; Oncology Institute, Sheba Tel Hashomer, Ramat Gan, Israel; Tel-Aviv University, Tel-Aviv, Israel.
  • Poortmans P; Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium.
  • Tsoutsou P; Hôpitaux Universitaires de Genève, Site de Cluse-Roseraie, Geneva, Switzerland.
  • Hajjaji N; Medical Oncology Department, Centre Oscar Lambret, Lille, France; Laboratoire Protéomique, Réponse Inflammatoire, et Spectrométrie De Masse (PRISM), Inserm U1192, Lille, France.
  • Russell N; Department of Radiotherapy, The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands.
  • Senkus E; Medical University of Gdansk, Gdansk, Poland.
  • Talbot JN; Institut National des Sciences et Techniques Nucléaires, CEA-Saclay, Paris, France.
  • Umutlu L; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
  • Vandecaveye V; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
  • Verhoeff JJC; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, Netherlands.
  • van Oordt WMH; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Zacho HD; Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark.
  • Cardoso F; Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal.
  • Fournier L; Université Paris Descartes Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
  • Van Duijnhoven F; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands.
  • Lecouvet FE; Department of Radiology, Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint-Luc, Institut du Cancer Roi Albert II, UCLouvain, Brussels, Belgium.
Lancet Oncol ; 24(8): e331-e343, 2023 08.
Article in En | MEDLINE | ID: mdl-37541279
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies Limits: Female / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies Limits: Female / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article